Group B streptococcal (GBS) infection remains the most common cause of neonatal early-
onset sepsis and a signiicant cause of late-onset sepsis among young infants …

Invasive disease due to group B Streptococcus infection (Streptococcus agalactiae) results
in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are …

Background Respiratory syncytial virus (RSV), a major cause of illness and death in infants
worldwide, could be prevented by vaccination during pregnancy. The efficacy …

Early-onset sepsis remains a common and serious problem for neonates, especially preterm
infants. Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia …

Streptococcus agalactiae or group B streptococcus (GBS) is a leading cause of serious
neonatal infections. GBS is an opportunistic commensal constituting a part of the intestinal …

Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease
since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the …

Streptococcus agalactiae (group B streptococcus (GBS)), remains the leading cause of
neonatal sepsis and meningitis in many countries and an important cause of disease in …

Group B streptococcus (GBS) remains a leading cause of serious neonatal infection despite
great progress in perinatal GBS disease prevention in the 1990s. In 1996, CDC, in …

Bacterial meningitis continues to be an important cause of mortality and morbidity in
neonates and children throughout the world. The introduction of the protein conjugate …

Since its emergence 25 years ago, group B streptococcus has become recognized as a
cause of serious illness in newborns, pregnant women, and adults with chronic medical …